Dr. Mark Ewusi Shiburah

Research Scientist

Brief Profile

Dr. Mark Ewusi Shiburah, is currently a Research Scientist at the Council for Scientific and Industrial Research (CSIR)-Animal Research Institute, specializing in genome editing and gene function studies. He earned his PhD in Genetics from the Sao Paulo State University, Brazil in 2024. Mark has about 5 peer-reviewed publications, 1 book chapter, several peer-reviewed conference abstracts and a developed protocol on Cell synchronization.

Mark first came to the CSIR in 2015 as an intern. He has been with the CSIR-Animal Research Institute as a permanent staff since 2019, engaged with research in diverse fields. Currently, his focus is on infectious disease and vaccine research. His immediate goals include understanding the genetic basis of resistance and susceptibility to tick and tick -borne diseases in cattle, designing and developing multi-epitope vaccines against zika and dengue, and the production of malaria vaccines, all of these projects aim to develop innovative solutions for disease prevention and control in both animals and humans.

He possesses an array of skills in Molecular Biology and Genetics, including immunofluoresence microscopy and multi-color flow cytometry. He is also proficient in different gene editing techniques, including CRISPR/Cas9, which he applied in his most recent project on finding therapeutic potential in the telomerase reverse transcriptase against Leishmaniases.

As a young career scientist, Mark is committed to developing and building sustainable international relationships aimed at improving the expertise needed for making vaccine decisions in Ghana. He is an active member of the American Chemical Society where he engages with the broader scientific community to stay updated on the latest advancements in the field. He aims to contribute to the global effort in combating infectious diseases through innovative research and international cooperation.

Feel free to reach out to Mark at markewusishiburah@gmail.com for potential collaborations.